| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CRL - Creightons Plc | SELL | -28 @ USD 123.61 | USD -3,461 | The ETF sold 28 shares of CRL on 2025-04-08. The shares were previously bought for an average price of USD 171.177. The Creightons Plc shares were sold for -27.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,332 The average price that the ETF previously sold CRL share for is USD 196.13 which is higher than the selling price of USD 123.61 on 2025-04-08. |
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 143.92 | USD -3,598 | The ETF sold 25 shares of DVA on 2025-04-08. The shares were previously bought for an average price of USD 156.212. The DaVita HealthCare Partners Inc shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of USD 307 The average price that the ETF previously sold DVA share for is USD 155.206 which is higher than the selling price of USD 143.92 on 2025-04-08. |
| TECH - Bio-Techne Corp | SELL | -85 @ USD 48.81 | USD -4,149 | The ETF sold 85 shares of TECH on 2025-04-08. The shares were previously bought for an average price of USD 67.0223. The Bio-Techne Corp shares were sold for -27.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,548 The average price that the ETF previously sold TECH share for is USD 72.1624 which is higher than the selling price of USD 48.81 on 2025-04-08. |
| HSIC - Henry Schein Inc | SELL | -67 @ USD 62.7 | USD -4,201 | The ETF sold 67 shares of HSIC on 2025-04-08. The shares were previously bought for an average price of USD 73.4903. The Henry Schein Inc shares were sold for -14.7% lower than average price of previous purchases. This resulted in an overall loss of USD 723 The average price that the ETF previously sold HSIC share for is USD 72.082 which is higher than the selling price of USD 62.7 on 2025-04-08. |
| MRNA - Moderna Inc | SELL | -180 @ USD 24.64 | USD -4,435 | The ETF sold 180 shares of MRNA on 2025-04-08. The shares were previously bought for an average price of USD 36.4077. The Moderna Inc shares were sold for -32.3% lower than average price of previous purchases. This resulted in an overall loss of USD 2,118 The average price that the ETF previously sold MRNA share for is USD 42.9108 which is higher than the selling price of USD 24.64 on 2025-04-08. |
| SOLV - Solventum Corp. | SELL | -72 @ USD 63.01 | USD -4,537 | The ETF sold 72 shares of SOLV on 2025-04-08. The shares were previously bought for an average price of USD 74.7865. The Solventum Corp. shares were sold for -15.7% lower than average price of previous purchases. This resulted in an overall loss of USD 848 The average price that the ETF previously sold SOLV share for is USD 71.5311 which is higher than the selling price of USD 63.01 on 2025-04-08. |
| VTRS - Viatris Inc | SELL | -646 @ USD 7.36 | USD -4,755 | The ETF sold 646 shares of VTRS on 2025-04-08. The shares were previously bought for an average price of USD 10.5684. The Viatris Inc shares were sold for -30.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,073 The average price that the ETF previously sold VTRS share for is USD 12.4272 which is higher than the selling price of USD 7.36 on 2025-04-08. |
| INCY - Incyte Corporation | SELL | -87 @ USD 56.97 | USD -4,956 | The ETF sold 87 shares of INCY on 2025-04-08. The shares were previously bought for an average price of USD 69.7854. The Incyte Corporation shares were sold for -18.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,115 The average price that the ETF previously sold INCY share for is USD 74.518 which is higher than the selling price of USD 56.97 on 2025-04-08. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 173.28 | USD -5,372 | The ETF sold 31 shares of UHS on 2025-04-08. The shares were previously bought for an average price of USD 190.165. The Universal Health Services Inc shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of USD 523 The average price that the ETF previously sold UHS share for is USD 196.905 which is higher than the selling price of USD 173.28 on 2025-04-08. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 144.32 | USD -5,628 | The ETF sold 39 shares of ALGN on 2025-04-08. The shares were previously bought for an average price of USD 190.424. The Align Technology Inc shares were sold for -24.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,798 The average price that the ETF previously sold ALGN share for is USD 220.664 which is higher than the selling price of USD 144.32 on 2025-04-08. |
| RVTY - Revvity Inc. | SELL | -67 @ USD 91.79 | USD -6,150 | The ETF sold 67 shares of RVTY on 2025-04-08. The shares were previously bought for an average price of USD 113.763. The Revvity Inc. shares were sold for -19.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,472 The average price that the ETF previously sold RVTY share for is USD 116.529 which is higher than the selling price of USD 91.79 on 2025-04-08. |
| HOLX - Hologic Inc | SELL | -121 @ USD 58.46 | USD -7,074 | The ETF sold 121 shares of HOLX on 2025-04-08. The shares were previously bought for an average price of USD 67.8373. The Hologic Inc shares were sold for -13.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,135 The average price that the ETF previously sold HOLX share for is USD 73.3277 which is higher than the selling price of USD 58.46 on 2025-04-08. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 190.39 | USD -7,425 | The ETF sold 39 shares of WST on 2025-04-08. The shares were previously bought for an average price of USD 264.303. The West Pharmaceutical Services Inc shares were sold for -28.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,883 The average price that the ETF previously sold WST share for is USD 305.686 which is higher than the selling price of USD 190.39 on 2025-04-08. |
| BAX - Baxter International Inc | SELL | -274 @ USD 27.97 | USD -7,664 | The ETF sold 274 shares of BAX on 2025-04-08. The shares were previously bought for an average price of USD 33.5164. The Baxter International Inc shares were sold for -16.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,520 The average price that the ETF previously sold BAX share for is USD 33.5129 which is higher than the selling price of USD 27.97 on 2025-04-08. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -110 @ USD 71.5 | USD -7,865 | The ETF sold 110 shares of COO on 2025-04-08. The shares were previously bought for an average price of USD 89.8782. The The Cooper Companies, Inc. Common Stock shares were sold for -20.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,022 The average price that the ETF previously sold COO share for is USD 98.9329 which is higher than the selling price of USD 71.5 on 2025-04-08. |
| BIIB - Biogen Inc | SELL | -79 @ USD 114.05 | USD -9,010 | The ETF sold 79 shares of BIIB on 2025-04-08. The shares were previously bought for an average price of USD 147.936. The Biogen Inc shares were sold for -22.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,677 The average price that the ETF previously sold BIIB share for is USD 161.618 which is higher than the selling price of USD 114.05 on 2025-04-08. |
| PODD - Insulet Corporation | SELL | -38 @ USD 247.04 | USD -9,388 | The ETF sold 38 shares of PODD on 2025-04-08. The shares were previously bought for an average price of USD 269.561. The Insulet Corporation shares were sold for -8.4% lower than average price of previous purchases. This resulted in an overall loss of USD 856 The average price that the ETF previously sold PODD share for is USD 262.167 which is higher than the selling price of USD 247.04 on 2025-04-08. |
| DGX - Quest Diagnostics Incorporated | SELL | -61 @ USD 159.8 | USD -9,748 | The ETF sold 61 shares of DGX on 2025-04-08. The shares were previously bought for an average price of USD 165.734. The Quest Diagnostics Incorporated shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of USD 362 The average price that the ETF previously sold DGX share for is USD 160.961 which is higher than the selling price of USD 159.8 on 2025-04-08. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 217.68 | USD -9,796 | The ETF sold 45 shares of LH on 2025-04-08. The shares were previously bought for an average price of USD 241.657. The Laboratory Corporation of America Holdings shares were sold for -9.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,079 The average price that the ETF previously sold LH share for is USD 238.274 which is higher than the selling price of USD 217.68 on 2025-04-08. |
| WAT - Waters Corporation | SELL | -32 @ USD 307.71 | USD -9,847 | The ETF sold 32 shares of WAT on 2025-04-08. The shares were previously bought for an average price of USD 373.416. The Waters Corporation shares were sold for -17.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,103 The average price that the ETF previously sold WAT share for is USD 376.432 which is higher than the selling price of USD 307.71 on 2025-04-08. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 307.71 | USD -9,847 | The ETF sold 32 shares of WAT on 2025-04-08. The shares were previously bought for an average price of USD 373.416. The MULETFWATIMETFP shares were sold for -17.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,103 The average price that the ETF previously sold WAT share for is USD 376.432 which is higher than the selling price of USD 307.71 on 2025-04-08. |
| MOH - MOH | SELL | -30 @ USD 330.66 | USD -9,920 | The ETF sold 30 shares of MOH on 2025-04-08. The shares were previously bought for an average price of USD 307.818. The MOH shares were sold for 7.4% higher than average price of previous purchases. This sale made a profit of USD 685 The average price that the ETF previously sold MOH share for is USD 312.647 so the ETF has sold 30 shares on 2025-04-08 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 330.66 | USD -9,920 | The ETF sold 30 shares of MOH on 2025-04-08. The shares were previously bought for an average price of USD 307.818. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 7.4% higher than average price of previous purchases. This sale made a profit of USD 685 The average price that the ETF previously sold MOH share for is USD 312.647 so the ETF has sold 30 shares on 2025-04-08 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 972.51 | USD -10,698 | The ETF sold 11 shares of MTD on 2025-04-08. The shares were previously bought for an average price of USD 1258.05. The Mettler-Toledo International Inc shares were sold for -22.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,141 The average price that the ETF previously sold MTD share for is USD 1256.91 which is higher than the selling price of USD 972.51 on 2025-04-08. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 972.51 | USD -10,698 | The ETF sold 11 shares of MTD on 2025-04-08. The shares were previously bought for an average price of USD 1258.05. The AMUNDI EUR GOV 710 shares were sold for -22.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,141 The average price that the ETF previously sold MTD share for is USD 1256.91 which is higher than the selling price of USD 972.51 on 2025-04-08. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -107 @ USD 102.79 | USD -10,999 | The ETF sold 107 shares of ZBH on 2025-04-08. The shares were previously bought for an average price of USD 107.997. The Zimmer Biomet Holdings Inc shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 557 The average price that the ETF previously sold ZBH share for is USD 109.183 which is higher than the selling price of USD 102.79 on 2025-04-08. |
| STE - STERIS plc | SELL | -54 @ USD 208.55 | USD -11,262 | The ETF sold 54 shares of STE on 2025-04-08. The shares were previously bought for an average price of USD 221.717. The STERIS plc shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of USD 711 The average price that the ETF previously sold STE share for is USD 217.996 which is higher than the selling price of USD 208.55 on 2025-04-08. |
| DXCM - DexCom Inc | SELL | -212 @ USD 60.69 | USD -12,866 | The ETF sold 212 shares of DXCM on 2025-04-08. The shares were previously bought for an average price of USD 78.5289. The DexCom Inc shares were sold for -22.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,782 The average price that the ETF previously sold DXCM share for is USD 74.2436 which is higher than the selling price of USD 60.69 on 2025-04-08. |
| IQV - IQVIA Holdings Inc | SELL | -91 @ USD 144.49 | USD -13,149 | The ETF sold 91 shares of IQV on 2025-04-08. The shares were previously bought for an average price of USD 196.411. The IQVIA Holdings Inc shares were sold for -26.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,725 The average price that the ETF previously sold IQV share for is USD 201.625 which is higher than the selling price of USD 144.49 on 2025-04-08. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -246 @ USD 58.75 | USD -14,453 | The ETF sold 246 shares of GEHC on 2025-04-08. The shares were previously bought for an average price of USD 86.443. The GE HealthCare Technologies Inc. shares were sold for -32.0% lower than average price of previous purchases. This resulted in an overall loss of USD 6,812 The average price that the ETF previously sold GEHC share for is USD 83.16 which is higher than the selling price of USD 58.75 on 2025-04-08. |
| A - Agilent Technologies Inc | SELL | -155 @ USD 99.29 | USD -15,390 | The ETF sold 155 shares of A on 2025-04-08. The shares were previously bought for an average price of USD 131.964. The Agilent Technologies Inc shares were sold for -24.8% lower than average price of previous purchases. This resulted in an overall loss of USD 5,064 The average price that the ETF previously sold A share for is USD 134.267 which is higher than the selling price of USD 99.29 on 2025-04-08. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 361.04 | USD -15,886 | The ETF sold 44 shares of IDXX on 2025-04-08. The shares were previously bought for an average price of USD 438.202. The IDEXX Laboratories Inc shares were sold for -17.6% lower than average price of previous purchases. This resulted in an overall loss of USD 3,395 The average price that the ETF previously sold IDXX share for is USD 430.289 which is higher than the selling price of USD 361.04 on 2025-04-08. |
| RMD - ResMed Inc | SELL | -80 @ USD 204.54 | USD -16,363 | The ETF sold 80 shares of RMD on 2025-04-08. The shares were previously bought for an average price of USD 235.04. The ResMed Inc shares were sold for -13.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,440 The average price that the ETF previously sold RMD share for is USD 243.912 which is higher than the selling price of USD 204.54 on 2025-04-08. |
| CAH - Cardinal Health Inc | SELL | -132 @ USD 125 | USD -16,500 | The ETF sold 132 shares of CAH on 2025-04-08. The shares were previously bought for an average price of USD 127.212. The Cardinal Health Inc shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 292 The average price that the ETF previously sold CAH share for is USD 122.118 so the ETF has sold 132 shares on 2025-04-08 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -271 @ USD 62.4 | USD -16,910 | The ETF sold 271 shares of CNC on 2025-04-08. The shares were previously bought for an average price of USD 60.1823. The Concurrent Technologies Plc shares were sold for 3.7% higher than average price of previous purchases. This sale made a profit of USD 601 The average price that the ETF previously sold CNC share for is USD 59.7573 so the ETF has sold 271 shares on 2025-04-08 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -65 @ USD 281.95 | USD -18,327 | The ETF sold 65 shares of HUM on 2025-04-08. The shares were previously bought for an average price of USD 272.131. The Hummingbird Resources PLC shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 638 The average price that the ETF previously sold HUM share for is USD 282.798 which is higher than the selling price of USD 281.95 on 2025-04-08. |
| HUM - Humana Inc | SELL | -65 @ USD 281.95 | USD -18,327 | The ETF sold 65 shares of HUM on 2025-04-08. The shares were previously bought for an average price of USD 272.131. The Humana Inc shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 638 The average price that the ETF previously sold HUM share for is USD 282.798 which is higher than the selling price of USD 281.95 on 2025-04-08. |
| EW - Edwards Lifesciences Corp | SELL | -320 @ USD 67.07 | USD -21,462 | The ETF sold 320 shares of EW on 2025-04-08. The shares were previously bought for an average price of USD 71.0156. The Edwards Lifesciences Corp shares were sold for -5.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,263 The average price that the ETF previously sold EW share for is USD 69.3765 which is higher than the selling price of USD 67.07 on 2025-04-08. |
| COR - Cencora Inc. | SELL | -94 @ USD 274.73 | USD -25,825 | The ETF sold 94 shares of COR on 2025-04-08. The shares were previously bought for an average price of USD 251.231. The Cencora Inc. shares were sold for 9.4% higher than average price of previous purchases. This sale made a profit of USD 2,209 The average price that the ETF previously sold COR share for is USD 247.693 so the ETF has sold 94 shares on 2025-04-08 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -156 @ USD 200.83 | USD -31,329 | The ETF sold 156 shares of BDX on 2025-04-08. The shares were previously bought for an average price of USD 231.159. The Becton Dickinson and Company shares were sold for -13.1% lower than average price of previous purchases. This resulted in an overall loss of USD 4,731 The average price that the ETF previously sold BDX share for is USD 226.21 which is higher than the selling price of USD 200.83 on 2025-04-08. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -57 @ USD 556.81 | USD -31,738 | The ETF sold 57 shares of REGN on 2025-04-08. The shares were previously bought for an average price of USD 714.539. The Regeneron Pharmaceuticals Inc shares were sold for -22.1% lower than average price of previous purchases. This resulted in an overall loss of USD 8,991 The average price that the ETF previously sold REGN share for is USD 775.043 which is higher than the selling price of USD 556.81 on 2025-04-08. |
| HCA - HCA Holdings Inc | SELL | -97 @ USD 332.18 | USD -32,221 | The ETF sold 97 shares of HCA on 2025-04-08. The shares were previously bought for an average price of USD 336.277. The HCA Holdings Inc shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 397 The average price that the ETF previously sold HCA share for is USD 335.571 which is higher than the selling price of USD 332.18 on 2025-04-08. |
| ZTS - Zoetis Inc | SELL | -243 @ USD 144.41 | USD -35,092 | The ETF sold 243 shares of ZTS on 2025-04-08. The shares were previously bought for an average price of USD 168.289. The Zoetis Inc shares were sold for -14.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,803 The average price that the ETF previously sold ZTS share for is USD 175.657 which is higher than the selling price of USD 144.41 on 2025-04-08. |
| MCK - McKesson Corporation | SELL | -68 @ USD 652.83 | USD -44,392 | The ETF sold 68 shares of MCK on 2025-04-08. The shares were previously bought for an average price of USD 612.44. The McKesson Corporation shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 2,747 The average price that the ETF previously sold MCK share for is USD 609.431 so the ETF has sold 68 shares on 2025-04-08 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -684 @ USD 67.63 | USD -46,259 | The ETF sold 684 shares of CVS on 2025-04-08. The shares were previously bought for an average price of USD 62.1919. The CVS Health Corp shares were sold for 8.7% higher than average price of previous purchases. This sale made a profit of USD 3,720 The average price that the ETF previously sold CVS share for is USD 57.7067 so the ETF has sold 684 shares on 2025-04-08 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -149 @ USD 313.84 | USD -46,762 | The ETF sold 149 shares of CI on 2025-04-08. The shares were previously bought for an average price of USD 313.959. The Cigna Corp shares were sold for 0.0% lower than average price of previous purchases. This resulted in an overall loss of USD 18 The average price that the ETF previously sold CI share for is USD 322.606 which is higher than the selling price of USD 313.84 on 2025-04-08. |
| ELV - Elevance Health Inc | SELL | -126 @ USD 430.9 | USD -54,293 | The ETF sold 126 shares of ELV on 2025-04-08. The shares were previously bought for an average price of USD 409.68. The Elevance Health Inc shares were sold for 5.2% higher than average price of previous purchases. This sale made a profit of USD 2,674 The average price that the ETF previously sold ELV share for is USD 410.082 so the ETF has sold 126 shares on 2025-04-08 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -126 @ USD 430.9 | USD -54,293 | The ETF sold 126 shares of ELV on 2025-04-08. The shares were previously bought for an average price of USD 409.68. The Elevance Health Inc shares were sold for 5.2% higher than average price of previous purchases. This sale made a profit of USD 2,674 The average price that the ETF previously sold ELV share for is USD 410.082 so the ETF has sold 126 shares on 2025-04-08 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -697 @ USD 81.88 | USD -57,070 | The ETF sold 697 shares of MDT on 2025-04-08. The shares were previously bought for an average price of USD 89.1446. The Medtronic PLC shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,063 The average price that the ETF previously sold MDT share for is USD 86.8079 which is higher than the selling price of USD 81.88 on 2025-04-08. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,102 @ USD 53.07 | USD -58,483 | The ETF sold 1102 shares of BMY on 2025-04-08. The shares were previously bought for an average price of USD 58.1196. The Bloomsbury Publishing Plc shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 5,565 The average price that the ETF previously sold BMY share for is USD 57.1616 which is higher than the selling price of USD 53.07 on 2025-04-08. |
| DHR - Danaher Corporation | SELL | -348 @ USD 174.64 | USD -60,775 | The ETF sold 348 shares of DHR on 2025-04-08. The shares were previously bought for an average price of USD 219.847. The Danaher Corporation shares were sold for -20.6% lower than average price of previous purchases. This resulted in an overall loss of USD 15,732 The average price that the ETF previously sold DHR share for is USD 235.401 which is higher than the selling price of USD 174.64 on 2025-04-08. |
| DHR - Danaher Corporation | SELL | -348 @ USD 174.64 | USD -60,775 | The ETF sold 348 shares of DHR on 2025-04-08. The shares were previously bought for an average price of USD 219.847. The Danaher Corporation shares were sold for -20.6% lower than average price of previous purchases. This resulted in an overall loss of USD 15,732 The average price that the ETF previously sold DHR share for is USD 235.401 which is higher than the selling price of USD 174.64 on 2025-04-08. |
| SYK - Stryker Corporation | SELL | -187 @ USD 337.37 | USD -63,088 | The ETF sold 187 shares of SYK on 2025-04-08. The shares were previously bought for an average price of USD 380.929. The Stryker Corporation shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of USD 8,146 The average price that the ETF previously sold SYK share for is USD 379.468 which is higher than the selling price of USD 337.37 on 2025-04-08. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -139 @ USD 472.37 | USD -65,659 | The ETF sold 139 shares of VRTX on 2025-04-08. The shares were previously bought for an average price of USD 477.045. The Vertex Pharmaceuticals Inc shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 650 The average price that the ETF previously sold VRTX share for is USD 480.9 which is higher than the selling price of USD 472.37 on 2025-04-08. |
| PFE - Pfizer Inc | SELL | -3,075 @ USD 21.84 | USD -67,158 | The ETF sold 3075 shares of PFE on 2025-04-08. The shares were previously bought for an average price of USD 26.0678. The Pfizer Inc shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of USD 13,000 The average price that the ETF previously sold PFE share for is USD 26.0737 which is higher than the selling price of USD 21.84 on 2025-04-08. |
| GILD - Guild Esports Plc | SELL | -676 @ USD 103.19 | USD -69,756 | The ETF sold 676 shares of GILD on 2025-04-08. The shares were previously bought for an average price of USD 102.556. The Guild Esports Plc shares were sold for 0.6% higher than average price of previous purchases. This sale made a profit of USD 429 The average price that the ETF previously sold GILD share for is USD 94.4799 so the ETF has sold 676 shares on 2025-04-08 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -801 @ USD 90.64 | USD -72,603 | The ETF sold 801 shares of BSX on 2025-04-08. The shares were previously bought for an average price of USD 98.4985. The Boston Scientific Corporation shares were sold for -8.0% lower than average price of previous purchases. This resulted in an overall loss of USD 6,295 The average price that the ETF previously sold BSX share for is USD 90.0301 so the ETF has sold 801 shares on 2025-04-08 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -801 @ USD 90.64 | USD -72,603 | The ETF sold 801 shares of BSX on 2025-04-08. The shares were previously bought for an average price of USD 98.4985. The MULSTRXSSXIMETFP shares were sold for -8.0% lower than average price of previous purchases. This resulted in an overall loss of USD 6,295 The average price that the ETF previously sold BSX share for is USD 90.0301 so the ETF has sold 801 shares on 2025-04-08 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -292 @ USD 280.26 | USD -81,836 | The ETF sold 292 shares of AMGN on 2025-04-08. The shares were previously bought for an average price of USD 304.248. The Amgen Inc shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of USD 7,004 The average price that the ETF previously sold AMGN share for is USD 298.229 which is higher than the selling price of USD 280.26 on 2025-04-08. |
| TMO - Time Out Group plc | SELL | -208 @ USD 419.31 | USD -87,216 | The ETF sold 208 shares of TMO on 2025-04-08. The shares were previously bought for an average price of USD 532.898. The Time Out Group plc shares were sold for -21.3% lower than average price of previous purchases. This resulted in an overall loss of USD 23,626 The average price that the ETF previously sold TMO share for is USD 530.669 which is higher than the selling price of USD 419.31 on 2025-04-08. |
| ISRG - Intuitive Surgical Inc | SELL | -194 @ USD 457.63 | USD -88,780 | The ETF sold 194 shares of ISRG on 2025-04-08. The shares were previously bought for an average price of USD 546.225. The Intuitive Surgical Inc shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of USD 17,187 The average price that the ETF previously sold ISRG share for is USD 532.753 which is higher than the selling price of USD 457.63 on 2025-04-08. |
| MRK - Marks Electrical Group PLC | SELL | -1,375 @ USD 78.95 | USD -108,556 | The ETF sold 1375 shares of MRK on 2025-04-08. The shares were previously bought for an average price of USD 93.1573. The Marks Electrical Group PLC shares were sold for -15.3% lower than average price of previous purchases. This resulted in an overall loss of USD 19,535 The average price that the ETF previously sold MRK share for is USD 100.31 which is higher than the selling price of USD 78.95 on 2025-04-08. |
| MRK - Merck & Company Inc | SELL | -1,375 @ USD 78.95 | USD -108,556 | The ETF sold 1375 shares of MRK on 2025-04-08. The shares were previously bought for an average price of USD 93.1573. The Merck & Company Inc shares were sold for -15.3% lower than average price of previous purchases. This resulted in an overall loss of USD 19,535 The average price that the ETF previously sold MRK share for is USD 100.31 which is higher than the selling price of USD 78.95 on 2025-04-08. |
| ABT - Abbott Laboratories | SELL | -941 @ USD 123.95 | USD -116,637 | The ETF sold 941 shares of ABT on 2025-04-08. The shares were previously bought for an average price of USD 126.267. The Abbott Laboratories shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,180 The average price that the ETF previously sold ABT share for is USD 117.997 so the ETF has sold 941 shares on 2025-04-08 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -959 @ USD 175.67 | USD -168,468 | The ETF sold 959 shares of ABBV on 2025-04-08. The shares were previously bought for an average price of USD 193.27. The AbbVie Inc shares were sold for -9.1% lower than average price of previous purchases. This resulted in an overall loss of USD 16,878 The average price that the ETF previously sold ABBV share for is USD 187.06 which is higher than the selling price of USD 175.67 on 2025-04-08. |
| JNJ - Johnson & Johnson | SELL | -1,308 @ USD 150 | USD -196,200 | The ETF sold 1308 shares of JNJ on 2025-04-08. The shares were previously bought for an average price of USD 157.739. The Johnson & Johnson shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of USD 10,123 The average price that the ETF previously sold JNJ share for is USD 154.971 which is higher than the selling price of USD 150 on 2025-04-08. |
| UNH - UnitedHealth Group Incorporated | SELL | -500 @ USD 553.08 | USD -276,540 | The ETF sold 500 shares of UNH on 2025-04-08. The shares were previously bought for an average price of USD 535.348. The UnitedHealth Group Incorporated shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 8,866 The average price that the ETF previously sold UNH share for is USD 582.289 which is higher than the selling price of USD 553.08 on 2025-04-08. |
| LLY - Eli Lilly and Company | SELL | -428 @ USD 726.24 | USD -310,831 | The ETF sold 428 shares of LLY on 2025-04-08. The shares were previously bought for an average price of USD 838.12. The Eli Lilly and Company shares were sold for -13.3% lower than average price of previous purchases. This resulted in an overall loss of USD 47,885 The average price that the ETF previously sold LLY share for is USD 803.375 which is higher than the selling price of USD 726.24 on 2025-04-08. |